Overview What is this medication? ATORVASTATIN (a TORE va sta tin) treats high cholesterol and reduces the risk of heart attack and stroke
What is atorvastatin used for? Atorvastatin is used to lower bad cholesterol and raise good cholesterol (HDL)
Angina Cardiovascular disease Heart attack Stroke NHS medicines information on atorvastatin – what it's used for, side effects, dosage and who can take it
Atorvastatin is metabolized by cytochrome P450 3A4; therefore, the concomitant use of drugs that inhibit CYP 3A4 can result in increased concentrations of
Lipitor (atorvastatin) belongs to a class of medications called HMG-CoA reductase inhibitors (statins)
When used in combination with a statin, fenofibrate, or other LDL-C lowering therapy, ZETIA is contraindicated in patients for whom a statin, fenofibrate, or other LDL-C
pinpoint red spots on the skin
These drugs block an enzyme in the body called HMG-CoA reductase
Atorvastatin is considered a moderate- or high-intensity statin depending upon the dose: A dose of 10 to 20 mg per day is considered moderate-intensity therapy with an expected LDL (low density lipoprotein) reduction of 30% to 50%
It showed that the risks of long-term use of statin drugs are low and the potential benefits are very high
7 million adults 75 years or older were taking a statin in 2013 to 2014, although it did not distinguish between statin use for primary vs secondary prevention
They are marketed Statin medications are used in the management and treatment of hypercholesteremia
This medicine may help prevent medical problems (eg, chest pain, heart attack, or stroke) that are caused by fats clogging the blood vessels
e
1: Clinical benefits and potential adverse effects of statin therapy
Atorvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood
Many people who take statins experience no or very few side effects
Atorvastatin is used together with a proper diet to lower cholesterol and triglyceride (fats) levels in the blood
Hair loss
A 2022 study published in The Lancet reviewed the records of over 150,000 people in randomized